CAS 265121-04-8
:Fosaprepitant dimeglumine
Description:
Fosaprepitant dimeglumine is a synthetic compound primarily used as an antiemetic in the prevention of nausea and vomiting associated with chemotherapy. It is a prodrug of aprepitant, which acts as a selective antagonist of the neurokinin-1 (NK1) receptor, thereby inhibiting the action of substance P, a neuropeptide involved in the vomiting reflex. The substance is characterized by its high solubility in water due to the presence of the dimeglumine moiety, which enhances its bioavailability. Fosaprepitant is typically administered intravenously and is known for its efficacy in combination with other antiemetic agents. Its pharmacokinetics include rapid conversion to aprepitant in the body, with a relatively long half-life, allowing for sustained antiemetic effects. Common side effects may include fatigue, dizziness, and gastrointestinal disturbances. As a therapeutic agent, fosaprepitant dimeglumine plays a crucial role in improving the quality of life for patients undergoing cancer treatment by effectively managing chemotherapy-induced nausea and vomiting.
Formula:C23H22F7N4O6P·2C7H17NO5
InChI:InChI=1S/C23H22F7N4O6P.C7H17NO5/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)40-20-19(13-2-4-17(24)5-3-13)33(6-7-39-20)11-18-31-21(35)34(32-18)41(36,37)38;1-8-2-4(10)6(12)7(13)5(11)3-9/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H,31,32,35)(H2,36,37,38);4-13H,2-3H2,1H3/t12-,19+,20-;4-,5+,6+,7+/m10/s1
InChI key:InChIKey=UGJUJYSRBQWCEK-GGXTVIBHSA-N
SMILES:C(N1[C@H]([C@@H](O[C@H](C)C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)OCC1)C3=CC=C(F)C=C3)C4=NN(P(=O)(O)O)C(=O)N4.[C@H]([C@@H]([C@@H](CO)O)O)([C@H](CNC)O)O
Synonyms:- 1-Deoxy-1-(Methylamino)-D-Glucitol [3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-2,5-Dihydro-5-Oxo-1H-1,2,4-Triazol-1-Yl]Phosphonate
- <span class="text-smallcaps">D</span>-Glucitol, 1-deoxy-1-(methylamino)-, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonate (2:1)
- <span class="text-smallcaps">D</span>-Glucitol, 1-deoxy-1-(methylamino)-, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonate (2:1) (salt)
- D-Glucitol, 1-deoxy-1-(methylamino)-, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4- morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)phosphonate (2:1) (salt)
- Fosaprepitant di(N-methylglucamine)
- Fosaprepitant dimeglumine [USAN]
- Ivemend
- Mk-0517
- Phosphonic acid, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
- Phosphonic acid, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-, compd. with 1-deoxy-1-(methylamino)-<span class="text-smallcaps">D</span>-glucitol (1:2)
- Unii-D35Fm8T64X
- Fosaprepitant dimeglumine
- Fosapitant Dimeglumine
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 12 products.
Fosaprepitant dimeglumine
CAS:Formula:C37H56F7N6O16PPurity:98%Color and Shape:SolidMolecular weight:1004.8337Fosaprepitant dimeglumine
CAS:<p>Fosaprepitant dimeglumine</p>Purity:≥95%Molecular weight:1004.83g/molRef: 54-BUP10189
1gTo inquire10mgTo inquire25mgTo inquire50mgTo inquire100mgTo inquire500mgTo inquireFosaprepitant Dimeglumine
CAS:Formula:C23H22F7N4O6P·2C7H17NO5Color and Shape:White To Off-White SolidMolecular weight:614.41 2*195.22Fosaprepitant-d4 Dimeglumine
CAS:Formula:C23H18D4F7N4O6P·2C7H17NO5Color and Shape:White To Off-White SolidMolecular weight:618.44 2*195.22Fosaprepitant Dimeglumine
CAS:Formula:C23H22F7N4O6P·2C7H17NO5Purity:>95.0%(HPLC)(qNMR)Color and Shape:White to Light yellow powder to crystalMolecular weight:1,004.84Fosaprepitant dimeglumine
CAS:<p>Fosaprepitant dimeglumine (MK-0517) is a soluble prodrug of aprepitant, which prevents nausea by blocking NK1 receptors.</p>Formula:C37H56F7N6O16PPurity:98% - 99.03%Color and Shape:SolidMolecular weight:1004.83Fosaprepitant Impurity 10
CAS:Formula:C23H22F7N4O7PColor and Shape:White To Off-White SolidMolecular weight:630.42Fosaprepitant-d4 Dimeglumine
CAS:Controlled Product<p>Applications Fosaprepitant-d4 Dimeglumine is a labeled analogue of Fosaprepitant Dimeglumine (F727305), a selective neurokinin-1 (NK-1) receptor antahonist. Fosaprepitant is an antiemetic drug, a Aprepitant (A729800) prodrug.<br>References Tattersall, F., et al.: Neuropharmacol., 39, 652 (2000), Cocquyt, V., et al.: Eur. J. Canc., 37, 835 (2001), Lasseter, K., et al.: J. Clin. Pharmacol., 47, 834 (2007), Marbury, T., et al.: Anesthes., Analges., 109, 418 (2009),<br></p>Formula:C37H52D4F7N6O16PColor and Shape:NeatMolecular weight:1008.86Fosaprepitant Dimeglumine
CAS:Controlled Product<p>Applications Fosaprepitant is a selective neurokinin-1 (NK-1) receptor antahonist. Fosaprepitant is an antiemetic drug, a Aprepitant (A729800) prodrug.<br>References Tattersall, F., et al.: Neuropharmacol., 39, 652 (2000), Cocquyt, V., et al.: Eur. J. Canc., 37, 835 (2001), Lasseter, K., et al.: J. Clin. Pharmacol., 47, 834 (2007), Marbury, T., et al.: Anesthes., Analges., 109, 418 (2009),<br></p>Formula:C23H22F7N4O6P·2C7H17NO5Color and Shape:White To Off-WhiteMolecular weight:1004.831-Deoxy-1-(methylamino)-D-glucitol [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]m ethyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonate
CAS:Fosaprepitant is a drug that belongs to the class of drugs used for chemotherapy. It is a prodrug that is converted in vivo to aprepitant, its active form. Fosaprepitant acts as an antagonist of the neurokinin-1 receptor (NK-1R) and inhibits the binding of substance P, which leads to an anti-inflammatory effect. Fosaprepitant has been shown to inhibit the production of substance P in animal models, leading to a reduction in inflammation. In clinical trials, fosaprepitant has been shown to be safe and well tolerated when used with other drugs such as cisplatin and docetaxel in patients with cancer.Formula:C23H22F7N4O6P•(C7H17NO5)2Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:1,004.83 g/molFosaprepitant-13C,15N3 Dimeglumine
CAS:Controlled ProductFormula:C36CH56F7N3N3O16PColor and Shape:NeatMolecular weight:1008.82







